Page last updated: 2024-10-20

porphobilinogen and Diabetes Mellitus, Type 2

porphobilinogen has been researched along with Diabetes Mellitus, Type 2 in 2 studies

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johns, M1
Fyalka, R1
Shea, JA1
Neumann, WL1
Rausaria, S1
Msengi, EN1
Imani-Nejad, M1
Zollars, H1
McPherson, T1
Schober, J1
Wooten, J1
Kwon, G1
Andersson, C1
Bylesjö, I1
Lithner, F1

Other Studies

2 other studies available for porphobilinogen and Diabetes Mellitus, Type 2

ArticleYear
SR-135, a peroxynitrite decomposing catalyst, enhances β-cell function and survival in B6D2F1 mice fed a high fat diet.
    Archives of biochemistry and biophysics, 2015, Volume: 577-578

    Topics: Animals; Apoptosis; Blood Glucose; Cell Survival; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose

2015
Effects of diabetes mellitus on patients with acute intermittent porphyria.
    Journal of internal medicine, 1999, Volume: 245, Issue:2

    Topics: Age of Onset; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Diabetes Mellitus, Type 2; Female;

1999